Cannabidiol reverses neuroimmune priming and microglial exhaustion in aged Gulf War Illness mice

Technical Summary: Cannabidiol Reverses Neuroimmune Priming and Microglial Exhaustion in Aged Gulf War Illness Mice

Problem Statement
Gulf War Illness (GWI) affects approximately 25–32% of 1990–1991 Gulf War veterans, presenting as a chronic, multi-symptom disorder characterized by cognitive impairment, fatigue, and mood dysregulation. The etiology is attributed to co-exposure to neurotoxicants (e.g., pyridostigmine bromide, permethrin, DEET, organophosphates) and physiological stress. While persistent low-grade neuroinflammation is established as a central driver of GWI pathology, the specific cellular substrates and mechanisms linking initial toxic exposure to long-term cognitive decline, particularly in the context of aging, remain unclear. Existing pharmacological therapies are limited. Furthermore, the interaction between chronic GWI-associated neuroinflammation and the biological aging process, which appears to accelerate neurocognitive decline in veterans, requires elucidation.

Methodology
The study utilized an established aged GWI mouse model (C57BL/6J mice exposed to GWI-relevant chemicals at 10 weeks, aged to 19 months) to investigate cellular and molecular alterations. The research employed a multi-resolution transcriptomic strategy integrating three distinct modalities:

1. Single-nucleus RNA sequencing (snRNA-seq): Performed on pooled hippocampal tissue from control (Ctrl) and GWI mice to map cell-type-specific alterations across nine broad lineages and 24 fine subtypes.
2. Whole-brain bulk RNA-seq: Conducted under both basal (PBS-injected) and immune-challenged (systemic LPS, 0.33 mg/kg) conditions to assess global neuroinflammatory responses.
3. FACS-purified microglial bulk RNA-seq: Microglia (CD45mid/CD11b+/CD11a−) were isolated from the same experimental groups to specifically characterize the microglial response independent of other brain cell types.

The study further evaluated the therapeutic potential of chronic cannabidiol (CBD) treatment (30 mg/kg, i.p., daily for 28 days followed by maintenance dosing) in aged GWI mice subjected to an acute LPS challenge. Data analysis included differential expression analysis, Gene Set Enrichment Analysis (GSEA), and functional module scoring across various statistical thresholds.

Key Results

• Multi-lineage Primed Neuroimmune Signature: snRNA-seq revealed a chronically primed neuroimmune state in the aged GWI hippocampus. While overall cellular composition was largely preserved, specific shifts were noted, including a reduction in excitatory neurons and an expansion of oligodendrocyte precursor cells (OPCs). Microglia exhibited a "primed" transcriptional state characterized by upregulated immune response genes (e.g., C1qa, C1qb, Stat3, Il6st) and a shift toward aerobic glycolysis in the activated microglial subset (Micro-Act), while homeostatic microglia (Micro-Homeo) retained the priming signature.
• Brain-Microglia Dissociation (The "Paradox"): Upon systemic LPS challenge, a striking dissociation was observed:
  • Whole Brain: GWI brains mounted an amplified neuroinflammatory response compared to controls, showing a 2.4-fold increase in differentially expressed genes (DEGs) and a 5.3-fold increase in enriched Gene Ontology terms. This included heightened leukocyte-mediated immunity, vascular/BBB engagement, and a profound suppression of synaptic translation and oxidative phosphorylation.
  • Microglia: In contrast, FACS-purified microglia from GWI mice were transcriptionally hyporesponsive to LPS. Unlike control microglia, which upregulated canonical activation modules (ribosome biogenesis, complement, phagocytosis), GWI microglia failed to activate these pathways. Instead, they showed inverted responses in antigen presentation and disease-associated microglia (DAM) modules, and significant downregulation of oxidative phosphorylation and mitochondrial translation genes. This defines a "microglial exhaustion" phenotype where the cells are primed at baseline but unable to mount a competent activation response upon challenge.
• CBD Intervention: Chronic CBD treatment partially rescued both arms of this dual phenotype:
  • At Baseline: CBD attenuated the constitutive priming state in GWI brains, suppressing elevated ribosome and oxidative phosphorylation programs.
  • Under LPS Challenge: CBD suppressed the GWI-amplified parenchymal hyper-inflammatory response (reducing leukocyte-mediated immunity terms). Crucially, in microglia, CBD partially restored competence functions, including antigen presentation and oxidative phosphorylation, and induced a proliferation program (mitotic cell cycle), suggesting cellular rejuvenation. However, CBD did not fully reverse the suppression of ribosome biogenesis driven by upstream regulators.

Key Contributions

1. Definition of a Dual Phenotype: The study identifies a coherent "brain-hyperresponsive/microglia-exhausted" phenotype as the cellular substrate of aged GWI. It demonstrates that the amplified neuroinflammation observed in GWI brain tissue is driven predominantly by non-microglial cells (astrocytes, endothelium, infiltrating leukocytes), while resident microglia are functionally compromised.
2. Mechanistic Insight into Microglial Exhaustion: The paper characterizes a specific state where microglia are chronically primed (sensitized) yet transcriptionally exhausted (unable to respond), a state distinct from simple activation or tolerance. This includes the inversion of antigen presentation and DAM modules upon immune challenge.
3. Therapeutic Validation of CBD: The study provides transcriptomic evidence that chronic CBD acts not merely as an acute immunosuppressant but as a modulator that "de-priming" chronically sensitized microglia and restoring their energetic and translational capacity, offering a potential pharmacological axis for GWI treatment.

Significance and Claims
The authors claim that their integrated multi-omics approach elucidates the cellular mechanisms underlying the treatment-refractory nature of GWI symptoms. They posit that the convergence of aging and chronic GWI-associated priming creates a unique neuroimmune environment where the brain is hyper-reactive to stressors while the primary immune cells (microglia) are exhausted and unable to resolve inflammation.

The paper asserts that CBD represents a translationally attractive strategy because it engages the endocannabinoid system to normalize this dual pathology: reducing the chronic priming load at baseline and restoring microglial competence (antigen presentation, oxidative metabolism) during acute immune challenges. The authors suggest this framework may extend to other chronic conditions involving primed parenchyma and compromised microglia, such as normal aging and post-acute sequelae of SARS-CoV-2 infection.

The study acknowledges limitations, including the use of pooled snRNA-seq replicates (precluding formal between-sample inference at the single-cell level), the reliance on transcriptomics without functional validation of phagocytosis or cytokine release, and the specific FACS gating strategy which may not resolve all border-associated macrophages. Despite these constraints, the convergence of three independent transcriptomic modalities supports the central finding of a biologically and therapeutically tractable dual phenotype.